PPAR-gamma agonists: Potential modulators of autophagy in obesity

Eur J Pharmacol. 2021 Dec 5:912:174562. doi: 10.1016/j.ejphar.2021.174562. Epub 2021 Oct 13.

Abstract

Autophagy pathways are involved in the pathogenesis of some obesity related health problems. As obesity is a nutrient sufficiency condition, autophagy process can be altered in obesity through AMP activated protein kinase (AMPK) inhibition. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) as the main modulator of adipogenesis process can be effective in the regulation of obesity related phenotypes. As well, it has been revealed that PPAR-gamma and its agonists can regulate autophagy in different normal or cancer cells. However, their effects on autophagy modulation in obesity have been investigated in the limited number of studies. In the current comprehensive mechanistic review, we aimed to investigate the possible mechanisms of action of PPAR-gamma on the process of autophagy in obesity through narrating the effects of PPAR-gamma on autophagy in the non-obesity conditions. Moreover, mode of action of PPAR-gamma agonists on autophagy related implications comprehensively reviewed in the various studies. Understanding the different effects of PPAR-gamma agonists on autophagy in obesity can help to develop a new approach to management of obesity.

Keywords: Adipogenesis; Autophagy; Lipophagy; Obesity; PPAR gamma.

Publication types

  • Review

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Animals
  • Autophagy / drug effects*
  • Autophagy / genetics
  • Autophagy / physiology*
  • Humans
  • Obesity / complications
  • Obesity / drug therapy*
  • Obesity / metabolism*
  • PPAR gamma / agonists*
  • PPAR gamma / metabolism*
  • Signal Transduction / drug effects

Substances

  • PPAR gamma
  • AMP-Activated Protein Kinases